Exxonmobil Investment Management Inc. TX decreased its stake in Mead Johnson Nutrition Co. (NYSE:MJN) by 2.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 47,150 shares of the company’s stock after selling 1,168 shares during the period. Exxonmobil Investment Management Inc. TX’s holdings in Mead Johnson Nutrition were worth $3,725,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of MJN. Northwestern Mutual Wealth Management Co. increased its position in shares of Mead Johnson Nutrition by 11.3% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,287 shares of the company’s stock worth $118,000 after buying an additional 131 shares in the last quarter. Pinkerton Retirement Specialists LLC acquired a new position in shares of Mead Johnson Nutrition during the second quarter worth $128,000. Checchi Capital Advisers LLC increased its position in shares of Mead Johnson Nutrition by 2.5% in the second quarter. Checchi Capital Advisers LLC now owns 1,418 shares of the company’s stock worth $129,000 after buying an additional 35 shares in the last quarter. Feltz Wealth PLAN Inc. acquired a new position in shares of Mead Johnson Nutrition during the second quarter worth $180,000. Finally, Ingalls & Snyder LLC acquired a new position in shares of Mead Johnson Nutrition during the second quarter worth $214,000. Hedge funds and other institutional investors own 94.72% of the company’s stock.

Institutional Ownership by Quarter for Mead Johnson Nutrition (NYSE:MJN)

Shares of Mead Johnson Nutrition Co. (NYSE:MJN) traded down 1.18% during midday trading on Monday, reaching $71.73. The company’s stock had a trading volume of 1,394,578 shares. The company has a 50-day moving average price of $75.83 and a 200-day moving average price of $82.57. The firm has a market cap of $13.25 billion, a price-to-earnings ratio of 26.66 and a beta of 1.43. Mead Johnson Nutrition Co. has a 12 month low of $65.53 and a 12 month high of $94.40.

Mead Johnson Nutrition (NYSE:MJN) last released its quarterly earnings results on Thursday, October 27th. The company reported $0.87 EPS for the quarter, topping the Zacks’ consensus estimate of $0.86 by $0.01. The company had revenue of $937.50 million for the quarter, compared to analyst estimates of $933.43 million. Mead Johnson Nutrition had a negative return on equity of 119.05% and a net margin of 13.26%. Mead Johnson Nutrition’s revenue was down 4.1% compared to the same quarter last year. During the same quarter last year, the firm posted $0.77 earnings per share. Equities analysts expect that Mead Johnson Nutrition Co. will post $3.45 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This article was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this article on another website, it was copied illegally and republished in violation of US and international copyright & trademark law. The correct version of this article can be accessed at https://www.thecerbatgem.com/2016/11/28/mead-johnson-nutrition-co-mjn-stake-cut-by-exxonmobil-investment-management-inc-tx.html.

A number of equities analysts have recently weighed in on MJN shares. Credit Suisse Group AG set a $95.00 target price on Mead Johnson Nutrition and gave the company a “buy” rating in a report on Wednesday, October 12th. Citigroup Inc. dropped their target price on Mead Johnson Nutrition from $106.00 to $103.00 and set a “buy” rating on the stock in a report on Thursday, September 8th. Susquehanna reiterated a “hold” rating and issued a $90.00 target price on shares of Mead Johnson Nutrition in a report on Wednesday, September 7th. Deutsche Bank AG reiterated a “hold” rating and issued a $88.00 target price (up previously from $85.00) on shares of Mead Johnson Nutrition in a report on Friday, October 21st. Finally, Goldman Sachs Group Inc. dropped their target price on Mead Johnson Nutrition from $96.00 to $85.00 and set a “neutral” rating on the stock in a report on Tuesday, September 27th. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $88.33.

In other news, Director Anna C. Catalano sold 656 shares of the firm’s stock in a transaction dated Monday, October 31st. The stock was sold at an average price of $74.99, for a total transaction of $49,193.44. Following the sale, the director now owns 8,796 shares of the company’s stock, valued at $659,612.04. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 0.50% of the company’s stock.

Mead Johnson Nutrition Company Profile

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.

5 Day Chart for NYSE:MJN

Receive News & Stock Ratings for Mead Johnson Nutrition Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mead Johnson Nutrition Co. and related stocks with our FREE daily email newsletter.